Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis

Figure 2

Forest plots of Hazard ratio (HR) on recurrence-free survival (adjuvant mitotane relative to nonmitotane) after resection of adrenocortical carcinoma in patients without distant metastasis. The square data markers represent log [HR] and horizontal lines represent 95% confidence interval (CI) of log [HR]. Marker size reflects the statistical weight of the meta-analysis. The diamond data marker represents the overall log [HR] and 95%CI for the outcome of interest.